Cargando…
Statin-Induced Autoimmune Necrotizing Myopathy
Statin therapy is a widely prescribed medication class for hypercholesterolemia. In statin-induced autoimmune myopathy, genetically predisposed and at-risk patients can develop antibodies against hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the key enzyme in the production of cholesterol. As a re...
Autores principales: | Jayatilaka, Sahani, Desai, Kunal, Rijal, Swarup, Zimmerman, Debra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255573/ https://www.ncbi.nlm.nih.gov/pubmed/34219515 http://dx.doi.org/10.1177/21501327211028714 |
Ejemplares similares
-
Statin-Induced Necrotizing Autoimmune Myopathy
por: Gawey, Brent, et al.
Publicado: (2020) -
Two Cases of Statin Induced Necrotizing Autoimmune Myopathy
por: Alam, Mustafa, et al.
Publicado: (2021) -
Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use
por: Sharma, Priyadarshani, et al.
Publicado: (2019) -
Statin‐associated necrotizing autoimmune myopathy with concurrent myasthenia gravis
por: Frasson, Emma, et al.
Publicado: (2021) -
Treatment of Statin-Induced Necrotizing Autoimmune Myopathy With Glucocorticoid Monotherapy
por: Lempel, Matthew, et al.
Publicado: (2020)